471 related articles for article (PubMed ID: 15948990)
1. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life.
Katugampola RP; Hongbo Y; Finlay AY
Br J Dermatol; 2005 Jun; 152(6):1256-62. PubMed ID: 15948990
[TBL] [Abstract][Full Text] [Related]
2. The practical reality of using a patient-reported outcome measure in a routine dermatology clinic.
Salek S; Roberts A; Finlay AY
Dermatology; 2007; 215(4):315-9. PubMed ID: 17911989
[TBL] [Abstract][Full Text] [Related]
3. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
4. Does enough quality of life-related discussion occur during dermatology outpatient consultations?
David SE; Ahmed Z; Salek MS; Finlay AY
Br J Dermatol; 2005 Nov; 153(5):997-1000. PubMed ID: 16225613
[TBL] [Abstract][Full Text] [Related]
5. Effect of vitiligo on self-reported health-related quality of life.
Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
[TBL] [Abstract][Full Text] [Related]
6. Psoriasis has a major secondary impact on the lives of family members and partners.
Eghlileb AM; Davies EE; Finlay AY
Br J Dermatol; 2007 Jun; 156(6):1245-50. PubMed ID: 17459044
[TBL] [Abstract][Full Text] [Related]
7. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
[TBL] [Abstract][Full Text] [Related]
8. Objective assessment of compliance with psoriasis treatment.
Zaghloul SS; Goodfield MJ
Arch Dermatol; 2004 Apr; 140(4):408-14. PubMed ID: 15096368
[TBL] [Abstract][Full Text] [Related]
9. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
[TBL] [Abstract][Full Text] [Related]
10. Assessment of severity of hand eczema: discrepancies between patient- and physician-rated scores.
van Coevorden AM; van Sonderen E; Bouma J; Coenraads PJ
Br J Dermatol; 2006 Dec; 155(6):1217-22. PubMed ID: 17107392
[TBL] [Abstract][Full Text] [Related]
11. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
[TBL] [Abstract][Full Text] [Related]
12. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
[TBL] [Abstract][Full Text] [Related]
13. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
Schöffski O; Augustin M; Prinz J; Rauner K; Schubert E; Sohn S; Reich K
J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
15. Does ad hoc quality-of-life discussion in inflammatory skin disease consultations reflect standardized patient-reported outcomes?
Davies E; Patel C; Salek MS; Finlay AY
Clin Exp Dermatol; 2008 Jan; 33(1):16-21. PubMed ID: 18076697
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life.
Holme SA; Anstey AV; Finlay AY; Elder GH; Badminton MN
Br J Dermatol; 2006 Sep; 155(3):574-81. PubMed ID: 16911284
[TBL] [Abstract][Full Text] [Related]
17. The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis.
Baron SE; Morris PK; Dye L; Fielding D; Goulden V
Br J Dermatol; 2006 May; 154(5):942-9. PubMed ID: 16634899
[TBL] [Abstract][Full Text] [Related]
18. Changes in quality of life in persons with eczema and psoriasis after treatment in departments of dermatology.
Wahl AK; Mørk C; Lillehol BM; Myrdal AM; Helland S; Hanestad BR; Moum T
Acta Derm Venereol; 2006; 86(3):198-201. PubMed ID: 16710574
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in psoriasis: an analysis of Psocare project patients.
Spandonaro F; Altomare G; Berardesca E; Calzavara-Pinton P; Chimenti S; Girolomoni G; Peserico A; Guerra AP; Vena GA; Polistena B; Ayala F
G Ital Dermatol Venereol; 2011 Jun; 146(3):169-77. PubMed ID: 21566546
[TBL] [Abstract][Full Text] [Related]
20. Sustained improvement of the quality of life of patients with psoriasis after hospitalization.
Vensel E; Hilley T; Trent J; Taylor JR; Kirsner RS; Kerdel FA; Taylor JR; Schwartzberg JB
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):858-60. PubMed ID: 11050595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
